Back to homepage

Endocrinology

Management of type 2 diabetes: consensus of diabetes organizations

Authors: Elaena Quattrocchi BS, PharmD, FASHP, CDE, Tamara Goldberg BS, PharmD, BCPS, Nino Marzella BS, MS, PharmD

This article reviews the recommendations of different diabetes organizations for achieving glycemic control.

More▸

Thyrotoxicosis after massive triiodothyronine (LT3) overdose: a coast-to-coast case series and review

Authors: Zhiheng H He MD, PhD, Yan Li MD, Nitin Trivedi MD, Sabrina Gill MD, James V Hennessey MD

Excessive exogenous thyroid hormone ingestion may lead to severe thyrotoxicosis and cause potential harm; this review of the literature suggests that thyroid hormone supplementation should not be used to alleviate nonspecific complaints in patients with normal endogenous thyroid function.

More▸

Clinical potential of treatment with semaglutide in type 2 diabetes patients

Authors: Michael E Røder

This review discusses the efficacy and safety of semaglutide, which have
been investigated in an extensive clinical development
program including more than 9,000 patients with type 2
diabetes.

More▸

Individualised requirements for optimum treatment of hypothyroidism: complex needs, limited options

Authors: Rudolf Hoermann, John E M Midgley, Rolf Larisch, Johannes W Dietrich

This review discusses levothyroxine therapy in the alleviation of hypothyroidism, focusing on complex needs, the available options and setpoints.

More▸

New uses and formulations of glucagon for hypoglycaemia

Authors: Pilar I Beato-Víbora PhD, Francisco J Arroyo-Díez PhD

Hypoglycaemia is a frequent complication of insulin
therapy. Injectable glucagon and oral intake of carbohydrates are
the recommended treatments for severe and non-severe
hypoglycaemic episodes, respectively. New uses and formulations of glucagon are reviewed and discussed in this article.

More▸